LAURUSLABS - Laurus Labs

Laurus Labs

LAURUSLABS · Pharma > Pharmaceuticals & Drugs · Chairman: M Venu Gopala Rao Listing date: Dec. 20, 2016 · Employees: 4808 · Hyderabad · http://www.lauruslabs.com

Stock Price vs Company Growth

3.9%

4.4%

4.7%

40.2%

87.4%

117.1%

24.6%

all

36.7%

🤔 How to analyze this graph?

Last Traded Price

₹ 1,941 3.9%

1,343

1,951

Company Overview

Sales

7,270 Cr

Growth: 15.1%

Profit after Tax

1,093 Cr

Growth: 23.0%

Large Cap

1,04,899 Cr

P/E: 96.1x

Industry P/E: 34.2x

Fundamentals

Sales (Cr)	₹ 7,270
Growth	15.1%
EBITDA	28.0%
P/S	14.4x
Dividend	0.2%
P/E	96.1x
Book Value	₹ 105
PEG Ratio	6.0x
ROE	20.9%
P/B	17.5x

Shareholding Pattern

Institutions

Amansa Holdings Private Limited

4.8 %

Anukar Projects Private Limited

3.2 %

Kalidindi Srihari Raju

3.04 %

New World Fund Inc

2.02 %

Societe Generale

1.23 %

Promoters

Satyanarayana Chava

16.58 %

Chava Naga Rani

6.55 %

Venkata Lakshman Rao Chunduru

2.51 %

Venkata Ravi Kumar Vantaram

1.44 %

Hymavathi Vantaram

0.04 %

Others

Increase Decrease No change

Company Profile Detailed

Laurus Labs is a research-driven pharmaceutical and biotechnology company committed to fostering sustainable growth and innovation in the pharmaceutical space globally. The company is an integrated pharmaceutical company, offering one-stop solution from clinical stage development to manufacturing scale.

Belongs to (51 Indices) view more

Investors (166)

veeraiah...

ramachan...

v.uma.ma...

Followers (8)

sunit

chanakya...

ravi_sha...